 TORONTO, Dec. 21, 2020 GLOBE NEWSWIRE -- Profound Medical Corp. NASDAQ:PROF; TSX:PRN Profound or the Company, the only company to provide customizable, incision-free therapies which combine real-time Magnetic Resonance Imaging MRI, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue, announced today that it has entered into a co-development agreement with GE Healthcare. 